OBFC2A-RARA-positive APL was demonstrated sensitive to ATRA in vitro, but the case achieved CR with DA plus ATRA, so whether its sensitivity to ATRA in vivo was also the same as in vitro remained unknown. The gene discussed is RARA; the disease is acute promyelocytic leukemia.